Syria Conflict Squeezes Drug Supplies for Major Diseases, WHO Says
This article was originally published in PharmAsia News
Syria’s local production of medicines, once 90% of the nation’s consumption, has been greatly reduced by the civil war in the country, particularly in the provinces of Aleppo, Damascus and Homs where local drug makers tended to congregate.
You may also be interested in...
Concession prices granted by the UK Department of Health and Social Care targeted some, but not all, of the fastest-rising generics prices in November. The average cost of some presentations more than trebled, according to the latest figures from WaveData.